Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Tolazamide | 1156-19-0 | 99.9% | 5 MG
SDP

Catalog No. 5000409314
Encompass_Preferred

Tolazamide (U-17835) is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (IC50 = 4.2 μM in HEK293 cells transfected with the human receptor). It has anti-diabetic properties, lowering blood glucose and decreasing insulin dose while maintaining adequate metabolic control. Tolazamide can also improve or normalize hyperglycemia and HbA.

  • Orally active sulfonylurea agent
  • Inhibits sulfonylurea receptor 1 (SUR1)
  • Lowers blood glucose
  • Decreases insulin dose
  • Maintains metabolic control
  • Improves or normalizes hyperglycemia and HbA
  • Attenuates gluconeogenesis and ketogenesis

Catalog No. 50-004-09314 Supplier Medchemexpress LLC Supplier No. HYB09205MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tolazamide (U-17835) is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (IC50 = 4.2 μM in HEK293 cells transfected with the human receptor). It has anti-diabetic properties, lowering blood glucose and decreasing insulin dose while maintaining adequate metabolic control. Tolazamide can also improve or normalize hyperglycemia and HbA.

  • Orally active sulfonylurea agent
  • Inhibits sulfonylurea receptor 1 (SUR1)
  • Lowers blood glucose
  • Decreases insulin dose
  • Maintains metabolic control
  • Improves or normalizes hyperglycemia and HbA
  • Attenuates gluconeogenesis and ketogenesis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.